Dopamine transmission in DYT1 dystonia.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D001345:Autoradiography; D001479:Basal Ganglia / Q000378:metabolism; D001549:Benzamides / Q000493:pharmacokinetics; D001552:Benzazepines / Q000493:pharmacokinetics; D001665:Binding Sites; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D018492:Dopamine Antagonists / Q000493:pharmacokinetics; D018765:Dopamine Uptake Inhibitors / Q000493:pharmacokinetics; D004421:Dystonia / Q000235:genetics / Q000378:metabolism*; D005192:Family Health; D006719:Homovanillic Acid / Q000032:analysis; D006801:Humans; D008454:Mazindol / Q000493:pharmacokinetics; D008562:Membrane Glycoproteins / Q000493:pharmacokinetics; D026901:Membrane Transport Proteins; D018832:Molecular Chaperones; D009479:Neuropeptides; D009435:Synaptic Transmission; D013747:Tetrabenazine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014316:Tritium / Q000493:pharmacokinetics; D050492:Vesicular Biogenic Amine Transport Proteins
D001549:Benzamides; D001552:Benzazepines; D002352:Carrier Proteins; D018492:Dopamine Antagonists; D018765:Dopamine Uptake Inhibitors; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D018832:Molecular Chaperones; D009479:Neuropeptides; C108175:TOR1A protein, human; D050492:Vesicular Biogenic Amine Transport Proteins; D014316:Tritium; D015102:3,4-Dihydroxyphenylacetic Acid; C032811:dihydrotetrabenazine; D008454:Mazindol; C030265:nemonapride; D004298:Dopamine; D006719:Homovanillic Acid; D013747:Tetrabenazine